Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics and Suicide and All-Cause Mortality in Patients With Newly Diagnosed Schizophrenia.

JAMA Netw Open · 2021 · PMC8114136 · PMID 33974056

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Regarding all-cause mortality, patients who switched to LAIs within 2 years had lower all-cause mortality than the OAP group (114 vs 129 deaths per 100 000 person-years), but the risk estimate did not reach statistical significance (aHR, 0.93; 95% CI, 0.67-1.30).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.